US Stock MarketDetailed Quotes

XLO Xilio Therapeutics

Watchlist
  • 1.280
  • +0.342+36.46%
Close Dec 20 16:00 ET
  • 1.240
  • -0.040-3.13%
Post 19:59 ET
56.27MMarket Cap-0.83P/E (TTM)

Xilio Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
2.26M
2.36M
0
0
0
0
0
0
0
0
Operating revenue
--2.26M
--2.36M
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-1.70%17.07M
-15.34%17.03M
-29.70%16.54M
-11.24%79.13M
-21.74%18.13M
-14.08%17.36M
-18.07%20.12M
10.85%23.53M
18.80%89.15M
18.46%23.17M
Selling and administrative expenses
-0.05%6.31M
-15.70%5.82M
-16.98%6.14M
-9.85%27M
-21.74%6.39M
-11.97%6.31M
-16.95%6.9M
17.31%7.4M
25.54%29.95M
-0.41%8.17M
-General and administrative expense
-0.05%6.31M
-15.70%5.82M
-16.98%6.14M
-9.85%27M
-21.74%6.39M
-11.97%6.31M
-16.95%6.9M
17.31%7.4M
25.54%29.95M
-0.41%8.17M
Research and development costs
-2.64%10.76M
-15.15%11.22M
-35.53%10.4M
-11.93%52.14M
-21.74%11.74M
-15.24%11.05M
-18.64%13.22M
8.12%16.13M
15.65%59.2M
32.11%15M
Operating profit
14.73%-14.8M
27.05%-14.67M
29.70%-16.54M
11.24%-79.13M
21.74%-18.13M
14.08%-17.36M
18.07%-20.12M
-10.85%-23.53M
-18.80%-89.15M
-18.46%-23.17M
Net non-operating interest income expense
Other net income (expense)
27.73%783K
-1.58%749K
-175.45%-664K
194.39%2.73M
-32.24%475K
47.36%613K
1,347.54%761K
782.17%880K
222.62%927K
583.45%701K
Special income (charges)
--41K
---30K
---948K
----
----
--0
--0
--0
----
----
-Less：Restructuring and merger&acquisition
---41K
--30K
--948K
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
21.04%742K
2.37%779K
-67.73%284K
194.39%2.73M
-32.24%475K
47.36%613K
1,347.54%761K
782.17%880K
222.62%927K
583.45%701K
Income before tax
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
13.40%-76.4M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-16.39%-88.22M
-14.03%-22.47M
Income tax
Net income
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
13.40%-76.4M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-16.39%-88.22M
-14.03%-22.47M
Net income continuous Operations
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
13.40%-76.4M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-16.39%-88.22M
-14.03%-22.47M
Minority interest income
Net income attributable to the parent company
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
13.40%-76.4M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-16.39%-88.22M
-14.03%-22.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
13.40%-76.4M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-16.39%-88.22M
-14.03%-22.47M
Basic earnings per share
63.93%-0.22
65.71%-0.24
25.30%-0.62
13.66%-2.78
21.95%-0.64
15.28%-0.61
22.22%-0.7
-6.41%-0.83
76.18%-3.22
16.33%-0.82
Diluted earnings per share
63.93%-0.22
65.71%-0.24
25.30%-0.62
13.66%-2.78
21.95%-0.64
15.28%-0.61
22.22%-0.7
-6.41%-0.83
76.18%-3.22
16.33%-0.82
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 2.26M2.36M00000000
Operating revenue --2.26M--2.36M--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -1.70%17.07M-15.34%17.03M-29.70%16.54M-11.24%79.13M-21.74%18.13M-14.08%17.36M-18.07%20.12M10.85%23.53M18.80%89.15M18.46%23.17M
Selling and administrative expenses -0.05%6.31M-15.70%5.82M-16.98%6.14M-9.85%27M-21.74%6.39M-11.97%6.31M-16.95%6.9M17.31%7.4M25.54%29.95M-0.41%8.17M
-General and administrative expense -0.05%6.31M-15.70%5.82M-16.98%6.14M-9.85%27M-21.74%6.39M-11.97%6.31M-16.95%6.9M17.31%7.4M25.54%29.95M-0.41%8.17M
Research and development costs -2.64%10.76M-15.15%11.22M-35.53%10.4M-11.93%52.14M-21.74%11.74M-15.24%11.05M-18.64%13.22M8.12%16.13M15.65%59.2M32.11%15M
Operating profit 14.73%-14.8M27.05%-14.67M29.70%-16.54M11.24%-79.13M21.74%-18.13M14.08%-17.36M18.07%-20.12M-10.85%-23.53M-18.80%-89.15M-18.46%-23.17M
Net non-operating interest income expense
Other net income (expense) 27.73%783K-1.58%749K-175.45%-664K194.39%2.73M-32.24%475K47.36%613K1,347.54%761K782.17%880K222.62%927K583.45%701K
Special income (charges) --41K---30K---948K----------0--0--0--------
-Less：Restructuring and merger&acquisition ---41K--30K--948K----------0--0--0--------
Other non- operating income (expenses) 21.04%742K2.37%779K-67.73%284K194.39%2.73M-32.24%475K47.36%613K1,347.54%761K782.17%880K222.62%927K583.45%701K
Income before tax 16.29%-14.02M28.05%-13.93M24.04%-17.2M13.40%-76.4M21.41%-17.66M15.37%-16.75M21.36%-19.36M-6.06%-22.65M-16.39%-88.22M-14.03%-22.47M
Income tax
Net income 16.29%-14.02M28.05%-13.93M24.04%-17.2M13.40%-76.4M21.41%-17.66M15.37%-16.75M21.36%-19.36M-6.06%-22.65M-16.39%-88.22M-14.03%-22.47M
Net income continuous Operations 16.29%-14.02M28.05%-13.93M24.04%-17.2M13.40%-76.4M21.41%-17.66M15.37%-16.75M21.36%-19.36M-6.06%-22.65M-16.39%-88.22M-14.03%-22.47M
Minority interest income
Net income attributable to the parent company 16.29%-14.02M28.05%-13.93M24.04%-17.2M13.40%-76.4M21.41%-17.66M15.37%-16.75M21.36%-19.36M-6.06%-22.65M-16.39%-88.22M-14.03%-22.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.29%-14.02M28.05%-13.93M24.04%-17.2M13.40%-76.4M21.41%-17.66M15.37%-16.75M21.36%-19.36M-6.06%-22.65M-16.39%-88.22M-14.03%-22.47M
Basic earnings per share 63.93%-0.2265.71%-0.2425.30%-0.6213.66%-2.7821.95%-0.6415.28%-0.6122.22%-0.7-6.41%-0.8376.18%-3.2216.33%-0.82
Diluted earnings per share 63.93%-0.2265.71%-0.2425.30%-0.6213.66%-2.7821.95%-0.6415.28%-0.6122.22%-0.7-6.41%-0.8376.18%-3.2216.33%-0.82
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.12%